Dimethoxycurcumin

CAS No. 160096-59-3

Dimethoxycurcumin( Veratrylcurcuminoid )

Catalog No. M27175 CAS No. 160096-59-3

Dimethoxycurcumin is an analog of curcumin with more metabolical stability. Dimethoxycurcumin induces epigenetic changes in leukemia cells and the expression of promoter methylated genes.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 48 In Stock
5MG 44 In Stock
10MG 70 In Stock
25MG 136 In Stock
50MG 233 In Stock
100MG 341 In Stock
200MG 486 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Dimethoxycurcumin
  • Note
    Research use only, not for human use.
  • Brief Description
    Dimethoxycurcumin is an analog of curcumin with more metabolical stability. Dimethoxycurcumin induces epigenetic changes in leukemia cells and the expression of promoter methylated genes.
  • Description
    Dimethoxycurcumin is an analog of curcumin with more metabolical stability. Dimethoxycurcumin induces epigenetic changes in leukemia cells and the expression of promoter methylated genes.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Veratrylcurcuminoid
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Akt1| Akt2| Akt3| PKA
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    160096-59-3
  • Formula Weight
    396.439
  • Molecular Formula
    C23H24O6
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (252.25 mM)
  • SMILES
    COc1ccc(\C=C\C(=O)CC(=O)\C=C\c2ccc(OC)c(OC)c2)cc1OC
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Blake JF, et al. Discovery and preclinical pharmacology of a selective ATP-competitive Akt inhibitor (GDC-0068) for the treatment of human tumors. J Med Chem. 2012 Sep 27;55(18):8110-27.
molnova catalog
related products
  • BI-0474

    BI-0474 is a potent KRASG12C inhibitor that inhibits GDP-KRAS::SOS1 protein-protein interactions with an IC50 value of 7.0 nM.BI-0474 exhibits significant antiproliferative activity against NCI-H358 cells harboring the G12C mutation, and shows significant anti-tumor activity in a non-small cell lung cancer xenograft model.

  • Mulberroside A

    Mulberroside has nephroprotective, hypoglycemic, and antidiabetic effects.

  • N-trans-caffeoyltyra...

    N-trans-caffeoyltyramine is a novel and potent modulator of inflammatory responses.